These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16579639)

  • 21. Delivery of rSLPI in a liposomal carrier for inhalation provides protection against cathepsin L degradation.
    Gibbons AM; McElvaney NG; Taggart CC; Cryan SA
    J Microencapsul; 2009 Sep; 26(6):513-22. PubMed ID: 18925490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced antigen presentation and CTL activity by transduction of mature rather than immature dendritic cells with octaarginine-modified liposomes.
    Homhuan A; Kogure K; Nakamura T; Shastri N; Harashima H
    J Control Release; 2009 May; 136(1):79-85. PubMed ID: 19344678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. S4(13)-PV cell penetrating peptide and cationic liposomes act synergistically to mediate intracellular delivery of plasmid DNA.
    Trabulo S; Mano M; Faneca H; Cardoso AL; Duarte S; Henriques A; Paiva A; Gomes P; Simões S; de Lima MC
    J Gene Med; 2008 Nov; 10(11):1210-22. PubMed ID: 18729238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disaccharide-modified liposomes and their in vitro intracellular uptake.
    Song CK; Jung SH; Kim DD; Jeong KS; Shin BC; Seong H
    Int J Pharm; 2009 Oct; 380(1-2):161-9. PubMed ID: 19635539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells.
    Li SD; Huang L
    Mol Pharm; 2006; 3(5):579-88. PubMed ID: 17009857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clickable functionalization of liposomes with the gH625 peptide from Herpes simplex virus type I for intracellular drug delivery.
    Tarallo R; Accardo A; Falanga A; Guarnieri D; Vitiello G; Netti P; D'Errico G; Morelli G; Galdiero S
    Chemistry; 2011 Nov; 17(45):12659-68. PubMed ID: 21956538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors.
    McNeeley KM; Karathanasis E; Annapragada AV; Bellamkonda RV
    Biomaterials; 2009 Aug; 30(23-24):3986-95. PubMed ID: 19427688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New packaging method of mycobacterial cell wall using octaarginine-modified liposomes: enhanced uptake by and immunostimulatory activity of dendritic cells.
    Homhuan A; Kogure K; Akaza H; Futaki S; Naka T; Fujita Y; Yano I; Harashima H
    J Control Release; 2007 Jul; 120(1-2):60-9. PubMed ID: 17467840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
    Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
    Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel peptide ligand directs liposomes toward EGF-R high-expressing cancer cells in vitro and in vivo.
    Song S; Liu D; Peng J; Deng H; Guo Y; Xu LX; Miller AD; Xu Y
    FASEB J; 2009 May; 23(5):1396-404. PubMed ID: 19124558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design of a Pep-1 peptide-modified liposomal nanocarrier system for intracellular drug delivery: Conformational characterization and cellular uptake evaluation.
    Kang MJ; Kim BG; Eum JY; Park SH; Choi SE; An JJ; Jang SH; Eum WS; Lee J; Lee MW; Kang K; Oh CH; Choi SY; Choi YW
    J Drug Target; 2011 Aug; 19(7):497-505. PubMed ID: 20738150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytosolic targeting of macromolecules using a pH-dependent fusogenic peptide in combination with cationic liposomes.
    Kobayashi S; Nakase I; Kawabata N; Yu HH; Pujals S; Imanishi M; Giralt E; Futaki S
    Bioconjug Chem; 2009 May; 20(5):953-9. PubMed ID: 19388672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct formation of proteo-liposomes by in vitro synthesis and cellular cytosolic delivery with connexin-expressing liposomes.
    Kaneda M; Nomura SM; Ichinose S; Kondo S; Nakahama K; Akiyoshi K; Morita I
    Biomaterials; 2009 Aug; 30(23-24):3971-7. PubMed ID: 19423159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracellular drug delivery by sulfatide-mediated liposomes to gliomas.
    Shao K; Hou Q; Duan W; Go ML; Wong KP; Li QT
    J Control Release; 2006 Oct; 115(2):150-7. PubMed ID: 16963144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes.
    Ramezani M; Khoshhamdam M; Dehshahri A; Malaekeh-Nikouei B
    Colloids Surf B Biointerfaces; 2009 Aug; 72(1):1-5. PubMed ID: 19395245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models.
    Kirpotin DB; Drummond DC; Shao Y; Shalaby MR; Hong K; Nielsen UB; Marks JD; Benz CC; Park JW
    Cancer Res; 2006 Jul; 66(13):6732-40. PubMed ID: 16818648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro stability and permeability studies of liposomal delivery systems for a novel lipophilic endomorphin 1 analogue.
    Koda Y; Liang MT; Blanchfield JT; Toth I
    Int J Pharm; 2008 May; 356(1-2):37-43. PubMed ID: 18272306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustained and specific in vitro inhibition of HIV-1 replication by a protease inhibitor encapsulated in gp120-targeted liposomes.
    Clayton R; Ohagen A; Nicol F; Del Vecchio AM; Jonckers TH; Goethals O; Van Loock M; Michiels L; Grigsby J; Xu Z; Zhang YP; Gutshall LL; Cunningham M; Jiang H; Bola S; Sarisky RT; Hertogs K
    Antiviral Res; 2009 Nov; 84(2):142-9. PubMed ID: 19699239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cationic liposomes loaded with doxorubicin targeting to the tumor neovasculature in vitro].
    Zhao W; Ma HL; Qi XR
    Yao Xue Xue Bao; 2007 Sep; 42(9):982-8. PubMed ID: 18050743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uptake of apolipoprotein E fragment coupled liposomes by cultured brain microvessel endothelial cells and intact brain capillaries.
    Hülsermann U; Hoffmann MM; Massing U; Fricker G
    J Drug Target; 2009 Sep; 17(8):610-8. PubMed ID: 19694613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.